Cargando…
Plasma-seq: a novel strategy for metastatic prostate cancer analysis
Personalized genomics will only be useful for monitoring the prognosis of patients with cancer when it becomes much more cost-effective and quicker to apply. A recent study brings this closer to reality with the development of plasma-seq, a rapid, low-cost method that sequences the circulating DNA p...
Autores principales: | Farris, Caitlin, Trimarchi, Jeffrey M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3706850/ https://www.ncbi.nlm.nih.gov/pubmed/23673197 http://dx.doi.org/10.1186/gm439 |
Ejemplares similares
-
Targeting B cells and plasma cells in autoimmune diseases: From established treatments to novel therapeutic approaches
por: Merino‐Vico, Ana, et al.
Publicado: (2022) -
In search for novel strategies towards neuroprotection and neuroregeneration: is PPARα a promising therapeutic target?
por: Moreno, Sandra, et al.
Publicado: (2015) -
Further analysis of PREVAIL: enzalutamide use in chemotherapy-naïve men with metastatic castration-resistant prostate cancer
por: Aragon-Ching, Jeanny B
Publicado: (2014) -
Circular RNA vaccine, a novel mRNA vaccine design strategy for SARS‐CoV‐2 and variants
por: Su, Peng, et al.
Publicado: (2022) -
Disrupting redox stabilizer: a novel therapeutic strategy for colorectal cancer
por: Trachootham, Dunyaporn, et al.
Publicado: (2019)